Toxicol Appl Pharmacol. 2007 Nov 1;224(3):274-83. Epub 2007 Jan 3.

Resveratrol: a review of preclinical studies for human cancer prevention.

Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, Kim AL.

Source

Department of Dermatology, College of Physicians and Surgeons, Columbia University, 630 West 168th Street VC15-204, New York, NY 10032, USA.

Abstract

The search for novel and effective cancer chemopreventive agents has led to the identification of various naturally occurring compounds one of which is resveratrol (trans-3,4',5-trihydroxystilbene), a phytoalexin derived from the skin of grapes and other fruits. Resveratrol is known to have potent anti-inflammatory and antioxidant effects and to inhibit platelet aggregation and the growth of a variety of cancer cells. Its potential chemopreventive and chemotherapeutic activities have been demonstrated in all three stages of carcinogenesis (initiation, promotion, and progression), in both chemically and UVB-induced skin carcinogenesis in mice, as well as in various murine models of human cancers. Evidence from numerous in vitro and in vivo studies has confirmed its ability to modulate various targets and signaling pathways. This review discusses the current preclinical and mechanistic data available and assesses resveratrol's anticancer effects to support its potential as an anticancer agent in human populations.

PMID:: 17306316; [PubMed - indexed for MEDLINE]
PMCID:: PMC2083123

Free PMC Article

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Medical

Cancer - MedlinePlus Health Information

Molecular Biology Databases

RESVERATROL - HSDB

Supplemental Content

Save items

Related citations in PubMed

Review New enlightenment of French Paradox: resveratrol's potential for cancer chemoprevention and anti-cancer therapy. [Cancer Biol Ther. 2007]
Review New enlightenment of French Paradox: resveratrol's potential for cancer chemoprevention and anti-cancer therapy.
Liu BL, Zhang X, Zhang W, Zhen HN. Cancer Biol Ther. 2007 Dec; 6(12):1833-6. Epub 2007 Oct 13.
Review Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. [Cancer Prev Res (Phila). 2009]
Review Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials.
Bishayee A. Cancer Prev Res (Phila). 2009 May; 2(5):409-18. Epub 2009 Apr 28.
Review Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). [Int J Oncol. 2003]
Review Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review).
Aziz MH, Kumar R, Ahmad N. Int J Oncol. 2003 Jul; 23(1):17-28.
Review Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. [Cancer Lett. 2008]
Review Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives.
Kundu JK, Surh YJ. Cancer Lett. 2008 Oct 8; 269(2):243-61. Epub 2008 Jun 11.
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. [Science. 1997]
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes.
Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, et al. Science. 1997 Jan 10; 275(5297):218-20.

See reviews... See all...

Cited by 25 PubMed Central articles

Resveratrol, MicroRNAs, Inflammation, and Cancer. [J Nucleic Acids. 2011]
Resveratrol, MicroRNAs, Inflammation, and Cancer.
Tili E, Michaille JJ. J Nucleic Acids. 2011; 2011:102431. Epub 2011 Aug 10.
Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics. [Cancer Prev Res (Phila). 2011]
Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics.
Howells LM, Berry DP, Elliott PJ, Jacobson EW, Hoffmann E, Hegarty B, Brown K, Steward WP, Gescher AJ. Cancer Prev Res (Phila). 2011 Sep; 4(9):1419-25. Epub 2011 Jun 16.
Nutritional interventions for cancer-induced cachexia. [Curr Probl Cancer. 2011]
Nutritional interventions for cancer-induced cachexia.
Gullett NP, Mazurak VC, Hebbar G, Ziegler TR. Curr Probl Cancer. 2011 Mar-Apr; 35(2):58-90.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Resveratrol: a review of preclinical studies for human cancer prevention.
Resveratrol: a review of preclinical studies for human cancer prevention.
Toxicol Appl Pharmacol. 2007 Nov 1 ;224(3):274-83. Epub 2007 Jan 3 .

PubMed
Stimulation of cysteinyl leukotriene production in mast cells by heat shock and ...
Stimulation of cysteinyl leukotriene production in mast cells by heat shock and acetylsalicylic acid.
Eur J Pharmacol. 2007 Apr 30 ;561(1-3):214-9. Epub 2007 Jan 20 .

PubMed
Alpha1-adrenergic receptor stimulation induces the expression of receptor activa...
Alpha1-adrenergic receptor stimulation induces the expression of receptor activator of nuclear factor kappaB ligand gene via protein kinase C and extracellular signal-regulated kinase pathways in MC3T3-E1 osteoblast-like cells.
Arch Oral Biol. 2007 Aug ;52(8):778-85. Epub 2007 Feb 15 .

PubMed
[How should the results of a research study be presented? II. The manuscript and...
[How should the results of a research study be presented? II. The manuscript and the publication process].
Cir Esp. 2007 Feb ;81(2):70-7.

PubMed
Combined vitamin C and E supplementation during pregnancy for preeclampsia preve...
Combined vitamin C and E supplementation during pregnancy for preeclampsia prevention: a systematic review.
Obstet Gynecol Surv. 2007 Mar ;62(3):202-6.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: